Vice Provost and Dean of Research
Showing 1,281-1,300 of 2,472 Results
-
Ronald Levy, MD
Robert K. and Helen K. Summy Professor in the School of Medicine
Current Research and Scholarly InterestsClinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer.
-
Adrian Lew
Professor of Mechanical Engineering
BioProf. Lew's interests lie in the broad area of computational solid mechanics. He is concerned with the fundamental design and mathematical analysis of material models and numerical algorithms.
Currently the group is focused on the design of algorithms to simulate hydraulic fracturing. To this end we work on algorithms for time-integration embedded or immersed boundary methods. -
Richard Lewis
Professor of Molecular and Cellular Physiology, Emeritus
Current Research and Scholarly InterestsWe study molecular mechanisms of calcium signaling with a focus on store-operated CRAC channels and their essential roles in T cell development and function. Currently we aim to define the molecular mechanism for CRAC channel activation and the means by which calcium signal dynamics mediate specific activation of transcription factors and T-cell genes during development.
-
Fei-Fei Li
Sequoia Capital Professor, Denning Co-Director (On Leave) Stanford Institute for Human-Centered AI, Senior Fellow at HAI and Professor, by courtesy, of Operations, Information and Technology at the Graduate School of Business
On Partial Leave from 01/01/2024 To 08/31/2027Current Research and Scholarly InterestsAI, Machine Learning, Computer Vision, Robotics, AI+Healthcare, Human Vision
-
Gordon Li, MD
Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences and of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly Interests1.) My laboratory studies the biology of brain tumors with the goal of developing novel therapeutics for the treatment of malignant brain tumors and translating that research into clinical trials.
2.) My clinical interests include improving surgical techniques for brain tumor surgery, immunotherapy for the treatment of glioblastoma, and novel uses for stereotactic radiosurgery. -
Jin Billy Li
Professor of Genetics
Current Research and Scholarly InterestsThe Li Lab is primarily interested in RNA editing mediated by ADAR enzymes. We co-discovered that the major function of RNA editing is to label endogenous dsRNAs as "self" to avoid being recognized as "non-self" by MDA5, a host innate immune dsRNA sensor, leading us to pursue therapeutic applications in cancer, autoimmune diseases, and viral infection. The other major direction of the lab is to develop technologies to harness endogenous ADAR enzymes for site-specific transcriptome engineering.
-
Lingyin Li
Professor of Biochemistry
BioDr. Li is a professor in the Biochemistry Department and ChEM-H Institute at Stanford. She is also a core investigator of the Arc Institute. Her lab works on understanding biochemical mechanisms of the immunotransmitter cGAMP and harnessing it to treat cancer and autoimmunity. She majored in chemistry at University of Science and Technology of China and graduated with a B. En in 2003. She then trained with Dr. Laura Kiessling, a pioneer in chemical biology, at University of Wisconsin-Madison and graduated with a Ph.D in chemistry in 2010. She obtained her postdoctoral training with Dr. Timothy Mitchison at Harvard Medical School, who introduced her to the field of chemical immunology. She started her lab at Stanford in 2015.
-
Minxing Li
Senior Licensing and Strategic Alliances Manager, Life Sciences, Office of Technology Licensing (OTL)
BioMinxing is a Licensing and Strategic Alliances Manager at Stanford OTL with a focus on life sciences technologies. Since she joined Stanford in 2020, she has been involved in protecting, marketing and licensing of Stanford's intellectual property. She is currently responsible for managing Stanford's alliances with the Parker Institute for Cancer Immunotherapy (PICI), where she works closely with investigators who are part of the PICI network and manages IP and licensing matters under the PICI relationship.
Prior to Stanford, Minxing worked as a consultant at IQVIA, Inc. -
Ron Li
Clinical Associate Professor, Medicine
BioRon Li is a Clinical Associate Professor of Medicine in the Division of Hospital Medicine and Center for Biomedical Informatics Research at Stanford University School of Medicine. As the Medical Informatics Director for Digital Health at Stanford Health Care, he provides medical and informatics direction for the health system's enterprise digital health portfolio, including expanding digital referral networks and virtual care modalities. He is also the founding Medical Director for Stanford Health Care at Home and the co-founder and Director for the Stanford Emerging Applications Lab (SEAL), which helps clinicians and staff build ideas into novel digital products that are prototyped and tested for care delivery at Stanford Health Care.
Ron's academic interests focus on the "delivery science" of new technological capabilities such as digital and artificial intelligence in healthcare and how to design, implement, and evaluate new tech enabled models of care delivery. Ron's work spans across multiple disciplines, including clinical medicine, data science, digital health, information technology, design thinking, process improvement, and implementation science. He has consulted for various companies in the digital health and artificial intelligence space. He is an attending physician on the inpatient medicine teaching service at Stanford Hospital and is the Associate Program Director for the Stanford Clinical Informatics Fellowship. -
Ruijiang Li
Associate Professor of Radiation Oncology (Radiation Physics)
Current Research and Scholarly InterestsMy lab's research is focused on the development of imaging and molecular biomarkers to improve cancer detection, diagnosis, prognostication, and prediction of therapy response. Our ultimate goal is to translate these biomarkers into clinical practice to guide optimal management and therapeutic decisions for precision cancer medicine.
-
Shanjun Li
Steven and Roberta Denning Global Sustainability Professor, Senior Fellow at the Freeman Spogli Institute for International Studies and at the Stanford Institute for Economic Policy Research
BioShanjun Li is the Steven and Roberta Denning Global Sustainability Professor and a Senior Fellow at both the Freeman Spogli Institute for International Studies (FSI) and the Stanford Institute for Economic Policy Research (SIEPR). His research focuses on environmental and energy economics, urban and transportation economics, empirical industrial organization, and the Chinese economy. His recent work examines pressing sustainability challenges and the rapid rise of clean energy industries in China, exploring their global implications to inform evidence-based policymaking.
-
Jiahao Liang
Ph.D. Student in Molecular and Cellular Physiology, admitted Autumn 2020
OTL Intern, Office of Technology Licensing (OTL)BioI'm currently a 6th-year Ph.D. student in Molecular & Cellular Physiology and an intern at the Office of Technology Licensing. I study how the spatial organization and structural conformation of synaptic proteins regulate synaptic transmission.
